Showing results (171-180 of 488) with videos related to

Sort By:
Pageof 49
Oncoimmunology|December 8, 2018
Impact of PD-L1 expression, driver mutations and clinical characteristics on survival after anti-PD-1/PD-L1 immunotherapy versus chemotherapy in non-small-cell lung cancer: A meta-analysis of randomized trialsQingyuan Huang, Hua Zhang, Josephine Hai, et al.
Pharmaceutics|December 5, 2019
Thermosensitive Liposome-Mediated Drug Delivery in Chemotherapy: Mathematical Modelling for Spatio-temporal Drug Distribution and Model-Based OptimisationYu Huang, Boram Gu, Cong Liu, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism|August 26, 2015
Noncoding RNAs and the control of signalling via nuclear receptor regulation in health and diseasePaul Cathcart, Walter Lucchesi, Silvia Ottaviani, et al.
Breast Cancer Research and Treatment|June 13, 2015
Venlafaxine in management of hot flashes in women with breast cancer: a systematic review and meta-analysisRamya Ramaswami, Marcos Daniel Villarreal, Dina Marie Pitta, et al.
Leukemia & Lymphoma|June 30, 2004
Resolution of AIDS-related Castleman's disease with anti-CD20 monoclonal antibodies is associated with declining IL-6 and TNF-alpha levelsTom Newsom-Davis, Mark Bower, Adrian Wildfire, et al.
Practical Radiation Oncology|March 29, 2014
Radiation dose and contralateral breast cancer risk associated with megavoltage cone-beam computed tomographic image verification in breast radiation therapyAlexandra Quinn, Lois Holloway, Eng-Siew Koh, et al.
Physics in Medicine and Biology|November 17, 2020
Validation of a new open-source method for automatic delineation and dose assessment of the heart and LADCA in breast radiotherapy with simultaneous uncertainty estimationRobert Finnegan, Ebbe Laugaard Lorenzen, Jason Dowling, et al.
Cancer Medicine|October 14, 2022
A pyroptosis-related lncRNA signature in bladder cancerPeng Wang, Zhiqiang Wang, Liping Zhu, et al.
AIDS (London, England)|July 11, 2003
A comparison of regimens based on non-nucleoside reverse transcriptase inhibitors or protease inhibitors in preventing Kaposi's sarcomaSimon Portsmouth, Justin Stebbing, Jas Gill, et al.
Expert Review of Anticancer Therapy|March 28, 2018
Total pathological complete response versus breast pathological complete response in clinical trials of reference and biosimilar trastuzumab in the neoadjuvant treatment of breast cancerJustin Stebbing, Yauheni Baranau, Alexey Manikhas, et al.
Pageof 49